[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
Identifieur interne : 000030 ( Main/Exploration ); précédent : 000029; suivant : 000031[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
Auteurs : Gabriela Andrade ; Frederico Sim Es Do Couto ; Luis Câmara-PestanaSource :
- Acta medica portuguesa [ 1646-0758 ] ; 2020.
Abstract
INTRODUCTION
The COVID-19 pandemic is a particularly relevant threat to mentally ill patients, and it constitutes a new challenge for health care providers. To the best of our knowledge, there is not any embracing published review about the use of psychotropic drugs during the COVID-19 pandemic.
MATERIALS AND METHODS
Non-systematic literature review. A search in the PubMed database was performed, with the terms 'psychotropic drugs', 'COVID-19', 'psychiatry' and 'pandemic'. Consensus and clinical guidelines about psychotropic drugs and COVID-19 approach, published by scientific societies, governmental entities and drug regulatory agencies were included.
RESULTS AND DISCUSSION
We present the recommendations about the use of psychotropic drugs during the COVID-19 pandemic, in the outpatient and inpatient settings. The treatment of affective bipolar disorder and schizophrenia have now added increased difficulties. Some psychotropic drugs interfere with the pathophysiology of the novel coronavirus infection and they could interact with the drugs used in the treatment of COVID-19. Some patients will need pharmacological interventions due to the presence of delirium. Smoking cessation changes the serum levels of some psychotropic drugs and may influence their use.
CONCLUSION
The COVID-19 pandemic has created new challenges in clinical practice. Psychiatric patients are a vulnerable population and often a careful clinical, laboratorial and electrocardiographic evaluation may be needed, particularly in those diagnosed with COVID-19. The regular treatment of mentally ill patients with COVID-19 presents increased complexity.
DOI: 10.20344/amp.13976
PubMed: 32705981
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].</title><author><name sortKey="Andrade, Gabriela" sort="Andrade, Gabriela" uniqKey="Andrade G" first="Gabriela" last="Andrade">Gabriela Andrade</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa; Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author><author><name sortKey="Sim Es Do Couto, Frederico" sort="Sim Es Do Couto, Frederico" uniqKey="Sim Es Do Couto F" first="Frederico" last="Sim Es Do Couto">Frederico Sim Es Do Couto</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Instituto de Farmacologia e Neurociências. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author><author><name sortKey="Camara Pestana, Luis" sort="Camara Pestana, Luis" uniqKey="Camara Pestana L" first="Luis" last="Câmara-Pestana">Luis Câmara-Pestana</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32705981</idno><idno type="pmid">32705981</idno><idno type="doi">10.20344/amp.13976</idno><idno type="wicri:Area/Main/Corpus">000013</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000013</idno><idno type="wicri:Area/Main/Curation">000013</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000013</idno><idno type="wicri:Area/Main/Exploration">000013</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].</title><author><name sortKey="Andrade, Gabriela" sort="Andrade, Gabriela" uniqKey="Andrade G" first="Gabriela" last="Andrade">Gabriela Andrade</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa; Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author><author><name sortKey="Sim Es Do Couto, Frederico" sort="Sim Es Do Couto, Frederico" uniqKey="Sim Es Do Couto F" first="Frederico" last="Sim Es Do Couto">Frederico Sim Es Do Couto</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Instituto de Farmacologia e Neurociências. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author><author><name sortKey="Camara Pestana, Luis" sort="Camara Pestana, Luis" uniqKey="Camara Pestana L" first="Luis" last="Câmara-Pestana">Luis Câmara-Pestana</name><affiliation><nlm:affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</nlm:affiliation><wicri:noCountry code="subField">Centro Hospitalar Universitário Lisboa Norte</wicri:noCountry></affiliation></author></analytic><series><title level="j">Acta medica portuguesa</title><idno type="eISSN">1646-0758</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>The COVID-19 pandemic is a particularly relevant threat to mentally ill patients, and it constitutes a new challenge for health care providers. To the best of our knowledge, there is not any embracing published review about the use of psychotropic drugs during the COVID-19 pandemic.</p></div><div type="abstract" xml:lang="en"><p><b>MATERIALS AND METHODS</b></p><p>Non-systematic literature review. A search in the PubMed database was performed, with the terms 'psychotropic drugs', 'COVID-19', 'psychiatry' and 'pandemic'. Consensus and clinical guidelines about psychotropic drugs and COVID-19 approach, published by scientific societies, governmental entities and drug regulatory agencies were included.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS AND DISCUSSION</b></p><p>We present the recommendations about the use of psychotropic drugs during the COVID-19 pandemic, in the outpatient and inpatient settings. The treatment of affective bipolar disorder and schizophrenia have now added increased difficulties. Some psychotropic drugs interfere with the pathophysiology of the novel coronavirus infection and they could interact with the drugs used in the treatment of COVID-19. Some patients will need pharmacological interventions due to the presence of delirium. Smoking cessation changes the serum levels of some psychotropic drugs and may influence their use.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The COVID-19 pandemic has created new challenges in clinical practice. Psychiatric patients are a vulnerable population and often a careful clinical, laboratorial and electrocardiographic evaluation may be needed, particularly in those diagnosed with COVID-19. The regular treatment of mentally ill patients with COVID-19 presents increased complexity.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32705981</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1646-0758</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Acta medica portuguesa</Title><ISOAbbreviation>Acta Med Port</ISOAbbreviation></Journal><ArticleTitle>[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.20344/amp.13976</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The COVID-19 pandemic is a particularly relevant threat to mentally ill patients, and it constitutes a new challenge for health care providers. To the best of our knowledge, there is not any embracing published review about the use of psychotropic drugs during the COVID-19 pandemic.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Non-systematic literature review. A search in the PubMed database was performed, with the terms 'psychotropic drugs', 'COVID-19', 'psychiatry' and 'pandemic'. Consensus and clinical guidelines about psychotropic drugs and COVID-19 approach, published by scientific societies, governmental entities and drug regulatory agencies were included.</AbstractText><AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">We present the recommendations about the use of psychotropic drugs during the COVID-19 pandemic, in the outpatient and inpatient settings. The treatment of affective bipolar disorder and schizophrenia have now added increased difficulties. Some psychotropic drugs interfere with the pathophysiology of the novel coronavirus infection and they could interact with the drugs used in the treatment of COVID-19. Some patients will need pharmacological interventions due to the presence of delirium. Smoking cessation changes the serum levels of some psychotropic drugs and may influence their use.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The COVID-19 pandemic has created new challenges in clinical practice. Psychiatric patients are a vulnerable population and often a careful clinical, laboratorial and electrocardiographic evaluation may be needed, particularly in those diagnosed with COVID-19. The regular treatment of mentally ill patients with COVID-19 presents increased complexity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa; Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simões do Couto</LastName><ForeName>Frederico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Instituto de Farmacologia e Neurociências. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Câmara-Pestana</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Serviço de Psiquiatria e Saúde Mental, Centro Hospitalar Universitário Lisboa Norte. Lisboa. Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Recomendações sobre a Utilização de Fármacos Psicotrópicos durante a Pandemia COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Acta Med Port</MedlineTA><NlmUniqueID>7906803</NlmUniqueID><ISSNLinking>0870-399X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="por"><AbstractText>Introdução: A pandemia de COVID-19 constitui uma ameaça particularmente relevante para os portadores de doença mental e um novo desafio para os profissionais que os acompanham. Até à data, tanto quanto sabemos, não existe qualquer revisão abrangente publicada relativamente à utilização de fármacos psicotrópicos durante a pandemia COVID-19. Material e Métodos: Revisão não sistemática da literatura. A pesquisa na PubMed foi realizada com os termos ‘psychotropic drugs’, ‘COVID-19’, ‘psychiatry’ e ‘pandemic’. Foram incluídos os consensos e as normas publicadas pelas sociedades científicas, entidades governamentais e agências regulamentares de medicamentos. Resultados e Discussão: Apresentam-se recomendações relativamente à utilização de psicofármacos durante a pandemia COVID-19, em contexto de ambulatório e de internamento. O tratamento da perturbação afetiva bipolar e da esquizofrenia tem agora dificuldades acrescidas. Alguns psicofármacos interferem com os mecanismos fisiopatológicos envolvidos na infeção pelo novo coronavírus e têm interações com os fármacos utilizados no tratamento da COVID-19. Em doentes com COVID-19 e com delirium, a utilização de psicofármacos poderá ser necessária. A cessação tabágica altera os níveis séricos de alguns psicofármacos e pode condicionar a sua utilização. Conclusão: A pandemia de COVID-19 coloca novos desafios na prática clínica. Os doentes psiquiátricos constituem uma população vulnerável, sendo frequentemente necessária uma avaliação clínica, laboratorial e eletrocardiográfica cuidadosa, naqueles com o diagnóstico de COVID-19. Os doentes mentais com COVID-19 apresentam uma complexidade acrescida na gestão da sua terapêutica habitual.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Pandemics</Keyword><Keyword MajorTopicYN="N">Psychiatry</Keyword><Keyword MajorTopicYN="N">Psychotropic Drugs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32705981</ArticleId><ArticleId IdType="doi">10.20344/amp.13976</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Andrade, Gabriela" sort="Andrade, Gabriela" uniqKey="Andrade G" first="Gabriela" last="Andrade">Gabriela Andrade</name><name sortKey="Camara Pestana, Luis" sort="Camara Pestana, Luis" uniqKey="Camara Pestana L" first="Luis" last="Câmara-Pestana">Luis Câmara-Pestana</name><name sortKey="Sim Es Do Couto, Frederico" sort="Sim Es Do Couto, Frederico" uniqKey="Sim Es Do Couto F" first="Frederico" last="Sim Es Do Couto">Frederico Sim Es Do Couto</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000030 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000030 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32705981
|texte= [Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32705981" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |